FRACCARO, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 4.349
EU - Europa 761
AS - Asia 590
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 5.705
Nazione #
US - Stati Uniti d'America 4.346
CN - Cina 270
IT - Italia 253
SG - Singapore 246
FI - Finlandia 119
SE - Svezia 104
GB - Regno Unito 85
DE - Germania 62
FR - Francia 49
UA - Ucraina 41
IN - India 31
VN - Vietnam 27
RU - Federazione Russa 25
HK - Hong Kong 8
IE - Irlanda 8
NL - Olanda 5
JP - Giappone 4
CA - Canada 3
AT - Austria 2
EU - Europa 2
GR - Grecia 2
TR - Turchia 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
Totale 5.705
Città #
Fairfield 642
Chandler 479
Woodbridge 375
Ashburn 316
Houston 301
Cambridge 238
Seattle 213
Singapore 203
Ann Arbor 200
Wilmington 196
Jacksonville 171
Santa Clara 157
Boardman 115
Princeton 97
San Diego 84
Medford 79
Beijing 72
Des Moines 71
Helsinki 71
Padova 52
Roxbury 49
Nanjing 42
Dong Ket 27
Milan 25
London 23
Ogden 22
New York 18
Rome 15
Hebei 11
Shenyang 11
Nanchang 10
Norwalk 10
Dublin 8
Falls Church 7
Hong Kong 7
Palermo 7
Redwood City 7
Cagliari 6
Changsha 6
Dearborn 6
Nashville 6
Schio 6
Los Angeles 5
Jiaxing 4
Kunming 4
Ningbo 4
Villorba 4
Westfield 4
Boydton 3
Carol Stream 3
Casamicciola Terme 3
Casier 3
Forlì 3
Genoa 3
Guangzhou 3
Mortara 3
Moscow 3
Ospedaletto Euganeo 3
Salerno 3
Zhengzhou 3
Amsterdam 2
Bollate 2
Borehamwood 2
Borås 2
Casoria 2
Chiswick 2
Civitavecchia 2
Costa Mesa 2
Dallas 2
Easton 2
Foggia 2
Forno 2
Hangzhou 2
Hanover 2
Hefei 2
Iseo 2
Jinan 2
Kharkiv 2
Kilburn 2
Marostica 2
Munich 2
Mussolente 2
Naples 2
Osaka 2
Phoenix 2
Portland 2
Redmond 2
Rockville 2
San Severino Marche 2
Shanghai 2
Taizhou 2
Temecula 2
Tianjin 2
Tokyo 2
Trieste 2
Vienna 2
Wenzhou 2
Wuhan 2
Yellow Springs 2
Acton 1
Totale 4.601
Nome #
Transcatheter aortic valve implantation in patients with severe left ventricular dysfunction: immediate and mid-term results, a multicenter study. 118
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 118
Development and validation of a distal embolization risk score during primary angioplasty in ST-elevation myocardial infarction 112
Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation 109
Safety and effectiveness of a selective strategy for coronary artery revascularization before transcatheter aortic valve implantation. 107
Early and Midterm Outcome of Propensity-Matched Intermediate-Risk Patients Aged ≥80 Years With Aortic Stenosis Undergoing Surgical or Transcatheter Aortic Valve Replacement (from the Italian Multicenter OBSERVANT Study) 106
Another passenger for the TAVR speeding train 105
Comparison of balloon-expandable versus self-expandable valves for transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction 104
Predictors and time-related impact of distal embolization during primary angioplasty 97
Myocardial abnormalities underlying persistent ST-segment elevation after anterior myocardial infarction 97
Impact of myocardial staining on In-hospital outcome after primary percutaneous coronary intervention in the Padua Registry on ST-elevation myocardial infarction 96
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 96
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 92
Time-dependent detrimental effects of distal embolization on myocardium and microvasculature during primary percutaneous coronary intervention. 91
Relation of aortic valve weight to severity of aortic stenosis. 89
Ventricular assist devices. 88
Transcatheter aortic valve implantation and bleeding: Focus on Valve Academic Research Consortium-2 classification. 87
Transcatheter aortic valve implantation 87
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy 86
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 84
Transcatheter aortic valve implantation and bleeding: focus on Valve Academic Research Consortium-2 classification. 83
Transcatheter aortic valve implantation at institutions without cardiovascular surgery departments: Many questions still linger before a paradigm shift 82
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 82
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 81
Age-related outcome of percutaneous mitral balloon valvuloplasty 79
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19 79
Transcatheter aortic valve implantation in patients younger than 75 years: Guidelines-based patients selection and clinical outcome 79
Intermediate clinical and hemodynamic outcomes after transcatheter aortic valve implantation presented at the fifty-first annual meeting of the society of thoracic surgeons, San Diego, CA, Jan 24-28, 2015 78
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 78
Conduction Abnormalities after Transcatheter Aortic Valve Implantation for Calcitic Aortic Valve Disease 75
Initial Q Wave at Presentation of Acute Myocardial Infarction is Better Than Time to Treatment in Predicting Myocardial and Microvascular Damage in Patients with Anterior Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 75
Renal insufficiency and left main coronary artery disease: reconsidering coronary intervention and bypass surgery 73
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction 72
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 71
Percutaneous treatment of spontaneous coronary artery dissection 70
Transfemoral aortic valve implantation of an Edwards Sapien XT valve in a patient with a mechanical mitral prosthesis. 70
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 70
Echocardiographic follow-up after transcatheter aortic valve replacement 68
[Updated SICI-GISE position paper on institutional and operator requirements for transcatheter aortic valve implantation] 68
Impact of Aortic Valve Replacement on Survival of Patients With Severe Aortic Stenosis With Low Transvalvular Gradient and Preserved Left Ventricular Ejection Fraction 66
Time-dependent Impact of Distal Embolization on Myocardial and Microvascular Damage During Primary-Percutaneous Coronary Intervention: a Prospective Magnetic Resonance Study 65
Eligibility to Percutaneous Aortic Valve Replacement in Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 64
Impact Of Multivessel Coronary Disease On Late Clinical Outcome In Patients With St-elevation Myocardial Infarction Is Not Due To The Extent Of Myocardial And Microvascular Injury Observed Early After Primary Angioplasty 64
Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis 64
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 63
Valve replacement for severe aortic stenosis with low transvalvular gradient and left ventricular ejection fraction exceeding 0.50. 62
Assessing the Impact of Distal Embolization on Myocardial and Microvascular Damage during primary-Percutaneous Coronary Intervention: A Prospective Magnetic Resonance Study 61
Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents. 61
Predictors and time-related impact of distal embolization during primary angioplasty. 61
Left ventricular outflow tract rupture during transcatheter aortic valve implantation: anatomic evidence of the vulnerable area 61
Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. 59
Predictors of distal embolization during direct angioplasty for acute myocardial infarction 58
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 57
Survival After Varying Revascularization Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: A Pairwise and Network Meta-Analysis 56
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study 54
Acute coronary syndrome with clear coronary artery: the case for concealed coronary hematoma. 53
Outcome of Coronary Ostial Stenting to Prevent Coronary Obstruction during Transcatheter Aortic Valve Replacement 53
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 53
Myocardial blush grade predicts myocardial and microvascular damage in ST-elevation myocardial infarction patients who underwent direct angioplasty 51
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International Registry 51
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses 51
Eligibility to Percutaneous Aortic Valve Replacement In Patients at High-Risk for Surgery. Insight from PUREVALVE Registry Selection Phase 50
Impact of High-Thrombus Burden Lesion on Distal Embolization and Myocardial Damage During Primary-Percutaneous Coronary Intervention: a Magnetic Resonance Study 49
Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. 49
Time-related impact of distal embolization on myocardial reperfusion after direct angioplasty 48
Incidence and Management of Vascular Complications in Percutaneous Aortic Valve Replacement 48
Improvement of symptoms and coronary perfusion gradient with mechanical left ventricular unloading in flow-limiting complex spontaneous coronary artery dissection, without revascularization 47
Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach 46
[High-risk ST-elevation acute coronary syndrome in a patient with multivessel coronary artery disease complicated by refractory cardiogenic shock undergoing complex percutaneous coronary revascularization: role and timing of mechanical circulatory support devices] 46
Coronary sinus reducer implantation in the middle cardiac vein for the treatment of refractory angina 46
Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results 46
Sleep quality in patients undergoing transcatheter aortic valve implantation (Tavi) 45
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement 45
Percutaneous mitral balloon valvuloplasty after surgical commissurotomy: a comparative study 44
Twilight-specific light cues 43
[The CHOICE study]. 42
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 41
The anatomy is the plastic image of function: the role of the ventricle-aortic angle in TAVR 40
Predictors of systemic embolism after successful balloon mitral valvuloplasty 35
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 34
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement 33
Prognosis of Mild and Moderate Aortic Stenosis 32
Percutaneous closure of a very wide interatrial septal defect: clinical case and literature review 32
Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3 31
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease 30
Prevalence and Prognostic Impact of Carotid Artery Disease in Patients Undergoing TAVI 28
Position paper of the Italian Society of Interventional Cardiology (SICI-GISE): Management of patent foramen ovale in patients with cerebral or systemic thromboembolism - 2020 27
Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction 26
Procedura percutanea combinata di riparazione dell’insufficienza mitralica con tecnica “edge-to-edge” e di chiusura dell’auricola sinistra 21
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type 5
Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters 3
Totale 5.802
Categoria #
all - tutte 26.558
article - articoli 26.190
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020448 0 0 0 0 0 0 73 108 72 77 85 33
2020/2021785 19 31 94 59 37 70 59 84 106 57 83 86
2021/20221.171 28 130 114 78 61 120 37 120 95 41 84 263
2022/2023999 194 102 36 117 131 131 8 46 96 16 50 72
2023/2024508 9 86 49 32 50 55 36 29 38 23 57 44
2024/2025683 18 131 90 78 285 81 0 0 0 0 0 0
Totale 5.802